Sharma Esseim, Chu Antony F
The Warren Alpert Medical School of Brown University, Providence, RI, USA.
J Interv Card Electrophysiol. 2018 Jan;51(1):77-86. doi: 10.1007/s10840-017-0303-1. Epub 2017 Dec 19.
Transcatheter aortic valve replacement (TAVR) is an increasingly prevalent therapy in patients with severe symptomatic aortic stenosis. Conduction disturbances requiring permanent pacemaker (PPM) implantation are a known complication of TAVR. This study investigated the progression of cardiac conduction disease in the post-TAVR pacemaker population and identified predictors of post-TAVR right ventricular (RV) pacing dependence.
Prospectively collected echocardiographic, ECG, and PPM interrogation data of 262 consecutive patients who underwent TAVR with placement of a balloon-expandable valve at one institution from March 2012 to October 2016 were analyzed.
A total of 25 patients (11.1%) required post-TAVR PPM implantation. Seventeen patients who received PPMs did not require RV pacing at 30 days. Nine of these 17 patients had no RV pacing requirement within 10 days. Pre-existing right bundle branch block (RBBB) (OR 105.4, 4.52-2458.5, p = 0.0002), bifascicular block (OR 12.50, 1.60-97.65, p = 0.02), intra-procedural complete heart block (OR 12.83, 1.26-130.52, p = 0.03), and QRS duration > 120 ms (OR 70.43, 3.23-1535.22, p = 0.0002) on pre-TAVR ECG were associated with RV pacing dependence at 30 days.
Sixty-eight percent of patients meeting post-procedural guideline indications for PPM did not require RV pacing at 30 days. Fifty-two percent of these patients demonstrated recovery of sinus node function or AV conduction within 10 days post-implant. RBBB, intra-procedural complete heart block, bifascicular block, and QRS duration > 120 ms were associated with RV pacing dependence at 30 days. These findings suggest that post-TAVR conduction disturbances may be acutely reversible in a significant proportion of patients receiving PPM within 10-30 days of implant.
经导管主动脉瓣置换术(TAVR)在重度有症状主动脉瓣狭窄患者中是一种越来越普遍的治疗方法。需要植入永久起搏器(PPM)的传导障碍是TAVR已知的并发症。本研究调查了TAVR术后起搏器植入人群中心脏传导疾病的进展情况,并确定了TAVR术后右心室(RV)起搏依赖的预测因素。
对2012年3月至2016年10月在一家机构连续接受TAVR并植入球囊扩张瓣膜的262例患者的前瞻性收集的超声心动图、心电图和PPM问询数据进行分析。
共有25例患者(11.1%)需要在TAVR术后植入PPM。17例接受PPM的患者在30天时不需要RV起搏。这17例患者中有9例在10天内不需要RV起搏。术前存在右束支传导阻滞(RBBB)(比值比[OR]105.4,4.52 - 2458.5,p = 0.0002)、双分支传导阻滞(OR 12.50,1.60 - 97.65,p = 0.02)、术中完全性心脏传导阻滞(OR 12.83,1.26 - 130.52,p = 0.03)以及TAVR术前心电图QRS时限>120 ms(OR 70.43,3.23 - 1535.22,p = 0.0002)与30天时的RV起搏依赖相关。
符合术后PPM指南指征的患者中有68%在30天时不需要RV起搏。这些患者中有52%在植入后10天内窦房结功能或房室传导恢复。RBBB、术中完全性心脏传导阻滞、双分支传导阻滞和QRS时限>120 ms与30天时的RV起搏依赖相关。这些发现表明TAVR术后传导障碍在植入后10 - 30天内接受PPM的相当一部分患者中可能是急性可逆的。